Literature DB >> 15974810

Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors.

Stephen J Qualman1, Jay Bowen, Patrick L Fitzgibbons, Susan L Cohn, Hiroyuki Shimada.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15974810     DOI： 10.5858/2005-129-874-PFTEOS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  5 in total

Review 1.  The efficient operation of the surgical pathology gross room.

Authors:  W C Bell; E S Young; P E Billings; W E Grizzle
Journal:  Biotech Histochem       Date:  2008-04       Impact factor: 1.718

2.  Expression and significance of HER family receptors in neuroblastic tumors.

Authors:  Ewa Izycka-Swieszewska; Agnieszka Wozniak; Elzbieta Drozynska; Jacek Kot; Wieslawa Grajkowska; Teresa Klepacka; Danuta Perek; Sylwia Koltan; Ewa Bien; Janusz Limon
Journal:  Clin Exp Metastasis       Date:  2011-01-04       Impact factor: 5.150

Review 3.  Opportunities and challenges of circulating biomarkers in neuroblastoma.

Authors:  Ricky M Trigg; Jacqui A Shaw; Suzanne D Turner
Journal:  Open Biol       Date:  2019-05-31       Impact factor: 6.411

4.  Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.

Authors:  Rana Zeine; Helen R Salwen; Radhika Peddinti; Yufeng Tian; Lisa Guerrero; Qiwei Yang; Alexandre Chlenski; Susan L Cohn
Journal:  Mod Pathol       Date:  2009-05-01       Impact factor: 7.842

5.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

Authors:  P F Ambros; I M Ambros; G M Brodeur; M Haber; J Khan; A Nakagawara; G Schleiermacher; F Speleman; R Spitz; W B London; S L Cohn; A D J Pearson; J M Maris
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.